GeneGlobe ID: UPFH0074781 | Cat. No.: | QuantiNova LNA Probe PCR Assays

HS_GLT1D1_195838 QuantiNova LNA Probe PCR Assay

Best coverage assay for GLT1D1
Assay targets 6 transcripts
Assay spans exon

Select a variant to see the price

Product Specification

null
Assay name​
HS_GLT1D1_195838 QuantiNova LNA Probe PCR Assay
Assay specification​
Best coverage assay for GLT1D1
Assay targets 6 transcripts
Assay spans exon
Gene symbol​
GLT1D1
Gene aliases​
FLJ31978
Species​
Homo sapiens
Main target​
ENST00000539044
Exons numbers​
2-3
Ensembl exons ids​
ENSE00003510470;ENSE00003567975
Amplicon start​
140
Amplicon length​
135
Assay targets​
Transcript Ensembl Id
Bio Type
Ccds
Ref Seq
Chromosome Location
ENST00000281703
Protein coding
CCDS9265
NM_144669
Chr.12: 128853478 - 128984968
ENST00000413816
Nonsense mediated decay
Chr.12: 128853603 - 128984300
ENST00000441390
Nonsense mediated decay
Chr.12: 128853427 - 128984956
ENST00000442111
Protein coding
NM_001366886
Chr.12: 128853494 - 128984956
ENST00000537468
Protein coding
Chr.12: 128864136 - 128983739
ENST00000539044
Nonsense mediated decay
Chr.12: 128853582 - 128930461

Resources

Kit Handbooks (1)
QuantiNova LNA Probe PCR Handbook
Safety Data Sheets (1)
Certificates of Analysis (1)
Introducing the HS_GLT1D1_195838 QuantiNova LNA Probe PCR Assay, a cutting-edge addition to our QuantiNova LNA Probe PCR Assays lineup, specifically designed for Real-Time PCR applications. This premium product offers unparalleled performance for researchers working with Human models. Leveraging advanced technology, the HS_GLT1D1_195838 QuantiNova LNA Probe PCR Assay facilitates accurate and reliable results, making it an indispensable tool for your scientific investigations. Whether you're conducting Real-Time PCR, or any other sophisticated analyses, this product from our QuantiNova LNA Probe PCR Assays collection ensures optimal efficiency and reproducibility for Human studies. Embrace the future of research with HS_GLT1D1_195838 QuantiNova LNA Probe PCR Assay and elevate your work to new heights.